Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Tumor Biology
Published in: Tumor Biology 1/2014

01-01-2014 | Research Article

TaqI polymorphism of VDR gene contributes to breast cancer risk

Authors: Hua Wang, Wenjian Wang, Dongjie Yang, Shenming Wang

Published in: Tumor Biology | Issue 1/2014

Login to get access

Abstract

Previous studies on the association of Vitamin D receptor (VDR) TaqI gene polymorphism with breast carcinogenesis have yielded inconsistent and inconclusive findings. The current meta-analysis was performed to provide a more precise assessment on the role of VDR TaqI polymorphism in breast cancer risk. 20 eligible case–control studies involving 9,055 cases and 10,516 controls were identified after a comprehensive literature search of the PubMed, Embase, Web of Science, and Wanfang databases. The pooled odds ratio (OR) with corresponding 95 % confidence interval (95 % CI) was calculated. Stratified analyses by ethnicity and study quality were conducted for further estimation. All statistical analyses were conducted by use of STATA (STATA Corporation, College Station, TX, Version 11.0). The overall ORs showed that the variant t allele and tt genotype were related to an increased risk of breast cancer (ORt vs. T = 1.05, 95 % CI 1.01–1.10, P OR = 0.025; ORtt vs. TT = 1.12, 95 % CI 1.03–1.23, P OR = 0.011; ORtt vs. Tt + TT = 1.10, 95 % CI 1.01–1.20, P OR = 0.023). Stratified analyses of studies in Caucasians and with high-quality further confirmed the results. However, no significant relationship was observed among Asians. This meta-analysis suggests that the VDR TaqI polymorphism confers risk effect on the breast cancer development, particularly in Caucasians.
Literature
1.
Arriagada G, Paredes R, van Wijnen AJ, Lian JB, van Zundert B, Stein GS, et al. 1alpha,25-dihydroxy vitamin D(3) induces nuclear matrix association of the 1alpha,25-dihydroxy vitamin D(3) receptor in osteoblasts independently of its ability to bind DNA. J Cell Physiol. 2010;222:336–46.PubMedCentralPubMedCrossRef
2.
Wu S, Sun J. Vitamin D, vitamin D receptor, and macroautophagy in inflammation and infection. Discov Med. 2011;11:325–35.PubMedCentralPubMed
3.
Holick MF. Vitamin D, and sunlight: strategies for cancer prevention and other health benefits. Clin J Am Soc Nephrol. 2008;3:1548–54.PubMedCrossRef
4.
Singh A, Kamen DL. Potential benefits of vitamin D for patients with systemic lupus erythematosus. Derma Endocrinol. 2012;4:146–51.CrossRef
5.
Whitfield GK, Hsieh JC, Jurutka PW, Selznick SH, Haussler CA, MacDonald PN, et al. Genomic actions of 1,25-dihydroxyvitamin D3. J Nutr. 1995;125:1690S–4S.PubMed
6.
Di Rosa M, Malaguarnera L, Nicolosi A, Sanfilippo C, Mazzarino C, Pavone P, et al. Vitamin D3: an ever green molecule. Front Biosci (Schol Ed). 2013;5:247–60.PubMedCrossRef
7.
Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, et al. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. J Endocrinol. 1997;154(Suppl):S57–73.PubMed
8.
Haussler MR, Jurutka PW, Hsieh JC, Thompson PD, Selznick SH, Haussler CA, et al. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone. Bone. 1995;17:33S–8S.PubMedCrossRef
9.
Bai YH, Lu H, Hong D, Lin CC, Yu Z, Chen BC. Vitamin D receptor gene polymorphisms and colorectal cancer risk: a systematic meta-analysis. World J Gastroenterol. 2012;18:1672–9.PubMedCrossRef
10.
Raimondi S, Johansson H, Maisonneuve P, Gandini S. Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis. 2009;30:1170–80.PubMedCrossRef
11.
Coughlin SS, Hall IJ. A review of genetic polymorphisms and prostate cancer risk. Ann Epidemiol. 2002;12:182–96.PubMedCrossRef
12.
Vuolo L, Di Somma C, Faggiano A, Colao A. Vitamin D and cancer. Front Endocrinol (Lausanne). 2012;3:58.
13.
Tang C, Chen N, Wu M, Yuan H, Du Y. Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat. 2009;117:391–9.PubMedCrossRef
14.
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.PubMedCrossRef
15.
Balasubramaniam SM, Rotti SB, Vivekanandam S. Risk factors of female breast carcinoma: a case control study at Puducherry. Indian J Cancer. 2013;50:65–70.PubMedCrossRef
16.
Anothaisintawee T, Wiratkapun C, Lerdsitthichai P, Kasamesup V, Wongwaisayawan S, Srinakarin J, et al. Risk factors of breast cancer: a systematic review and meta-analysis. Asia Pac J Public Health. 2013.
17.
Tang LY, Chen LJ, Qi ML, Su Y, Su FX, Lin Y, et al. Effects of passive smoking on breast cancer risk in pre/post-menopausal women as modified by polymorphisms of PARP1 and ESR1. Gene. 2013.
18.
Romanowicz-Makowska H, Smolarz B, Zadrozny M, Westfal B, Baszczynski J, Polac I, et al. Single nucleotide polymorphisms in the homologous recombination repair genes and breast cancer risk in Polish women. Tohoku J Exp Med. 2011;224:201–8.PubMedCrossRef
19.
Krupa R, Synowiec E, Pawlowska E, Morawiec Z, Sobczuk A, Zadrozny M, et al. Polymorphism of the homologous recombination repair genes RAD51 and XRCC3 in breast cancer. Exp Mol Pathol. 2009;87:32–5.PubMedCrossRef
20.
Synowiec E, Stefanska J, Morawiec Z, Blasiak J, Wozniak K. Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patients. Mutat Res. 2008;648:65–72.PubMedCrossRef
21.
Mishra DK, Wu Y, Sarkissyan M, Sarkissyan S, Chen Z, Shang X, et al. Vitamin D receptor gene polymorphisms and prognosis of breast cancer among African–American and Hispanic women. PLoS One. 2013;8:e57967.PubMedCentralPubMedCrossRef
22.
Liu D, Zhang H, Zou T, Zhang Y, Yang Z, Ye T. Association between the genetic polymorphisms of Vitamin D receptor and sporadic breast cancer risk in Yunnan women of Han nationality. J Kunming Med Univer. 2011;32:91–4. Article in Chinese.
23.
Engel LS, Orlow I, Sima CS, Satagopan J, Mujumdar U, Roy P, et al. Vitamin D receptor gene haplotypes and polymorphisms and risk of breast cancer: a nested case–control study. Cancer Epidemiol Biomarker Prev. 2012;21:1856–67.CrossRef
24.
Huang Y, Lu H, Bai Y, Chen Y, Zeng Y, Pan Y. Relationship between genptypes and haplotypes of Vitamin D receptor gene and breast cancer risk. Zhonghua Liu Xing Bing Xue Za Zhi. 2012;41:89–92. Article in Chinese.
25.
Anderson LN, Cotterchio M, Cole DE, Knight JA. Vitamin D-related genetic variants, interactions with vitamin D exposure, and breast cancer risk among Caucasian women in Ontario. Cancer Epidemiol Biomarker Prev. 2011;20:1708–17.CrossRef
26.
Gapska P, Scott RJ, Serrano-Fernandez P, Huzarski T, Byrski T, Kladny J, et al. Vitamin D receptor variants and breast cancer risk in the Polish population. Breast Cancer Res Treat. 2009;115:629–33.PubMedCrossRef
27.
Chakraborty A, Mishra AK, Soni A, Regina T, Mohil R, Bhatnagar D, et al. Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians. Cancer Detect Prev. 2009;32:386–94.PubMedCrossRef
28.
Abbas S, Nieters A, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, et al. Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk. Breast Cancer Res. 2008;10:R31.PubMedCentralPubMedCrossRef
29.
McCullough ML, Stevens VL, Diver WR, Feigelson HS, Rodriguez C, Bostick RM, et al. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case–control study. Breast Cancer Res. 2007;9:R9.PubMedCentralPubMedCrossRef
30.
John EM, Schwartz GG, Koo J, Wang W, Ingles SA. Sun exposure, vitamin D receptor gene polymorphisms, and breast cancer risk in a multiethnic population. Am J Epidemiol. 2007;166:1409–19.PubMedCrossRef
31.
Sillanpaa P, Hirvonen A, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, et al. Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer risk. Pharmacogenetics. 2004;14:239–45.PubMedCrossRef
32.
Buyru N, Tezol A, Yosunkaya-Fenerci E, Dalay N. Vitamin D receptor gene polymorphisms in breast cancer. Exp Mol Med. 2003;35:550–5.PubMedCrossRef
33.
Newcomb PA, Kim H, Trentham-Dietz A, Farin F, Hunter D, Egan KM. Vitamin D receptor polymorphism and breast cancer risk. Cancer Epidemiol Biomarker Prev. 2002;11:1503–4.
34.
Hou MF, Tien YC, Lin GT, Chen CJ, Liu CS, Lin SY, et al. Association of vitamin D receptor gene polymorphism with sporadic breast cancer in Taiwanese patients. Breast Cancer Res Treat. 2002;74:1–7.PubMedCrossRef
35.
Cui J, Shen K, Shen Z, Jiang F, Shen F. Relationship of vitamin D receptor polymorphism with breast cancer. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2001;18:286–8.PubMed
36.
Lundin AC, Soderkvist P, Eriksson B, Bergman-Jungestrom M, Wingren S. Association of breast cancer progression with a vitamin D receptor gene polymorphism South-East Sweden Breast Cancer Group. Cancer Res. 1999;59:2332–4.PubMed
37.
Dunning AM, McBride S, Gregory J, Durocher F, Foster NA, Healey CS, et al. No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer. Carcinogenesis. 1999;20:2131–5.PubMedCrossRef
38.
Curran JE, Vaughan T, Lea RA, Weinstein SR, Morrison NA, Griffiths LR. Association of A vitamin D receptor polymorphism with sporadic breast cancer development. Int J Cancer. 1999;83:723–6.PubMedCrossRef
39.
Salanti G, Amountza G, Ntzani EE, Ioannidis JP. Hardy–Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power. Eur J Hum Genet. 2005;13:840–8.PubMedCrossRef
40.
Cochran WG. The comparison of percentages in matched samples. Biometrika. 1950;37:256–66.PubMed
41.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.PubMedCrossRef
42.
Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMed
43.
44.
Stuck AE, Rubenstein LZ, Wieland D. Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ. 1998;316:469. author reply 70–1.PubMedCrossRef
45.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.PubMedCrossRef
46.
Fang Y, van Meurs JB, D’Alesio A, Jhamai M, Zhao H, Rivadeneira F, et al. Promoter and 3′-untranslated-region haplotypes in the vitamin D receptor gene predispose to osteoporotic fracture: the Rotterdam study. Am J Hum Genet. 2005;77:807–23.PubMedCentralPubMedCrossRef
47.
Crofts LA, Hancock MS, Morrison NA, Eisman JA. Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts. Proc Natl Acad Sci U S A. 1998;95:10529–34.PubMedCentralPubMedCrossRef
48.
Carlberg C, Dunlop TW. The impact of chromatin organization of vitamin D target genes. Anticancer Res. 2006;26:2637–45.PubMed
49.
Whitfield GK, Remus LS, Jurutka PW, Zitzer H, Oza AK, Dang HT, et al. Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol. 2001;177:145–59.PubMedCrossRef
50.
Yazici D, Yavuz D, Tarcin O, Sancak S, Deyneli O, Akalin S. Vitamin D receptor gene ApaI, TaqI, FokI and BsmI polymorphisms in a group of Turkish patients with Hashimoto's thyroiditis. Minerva Endocrinol. 2013;38:195–201.PubMed
51.
Li L, Wu B, Liu JY, Yang LB. Vitamin D Receptor Gene Polymorphisms and type 2 diabetes: a meta-analysis. Arch Med Res. 2013;44:235–41.PubMedCrossRef
52.
Stefanic M, Rucevic I, Barisic-Drusko V. Meta-analysis of vitamin D receptor polymorphisms and psoriasis risk. Int J Dermatol. 2013;52:705–10.PubMedCrossRef
53.
54.
Touvier M, Chan DS, Lau R, Aune D, Vieira R, Greenwood DC, et al. Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarker Prev. 2011;20:1003–16.CrossRef
55.
Habuchi T, Suzuki T, Sasaki R, Wang L, Sato K, Satoh S, et al. Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population. Cancer Res. 2000;60:305–8.PubMed
56.
Tozlu S, Girault I, Vacher S, Vendrell J, Andrieu C, Spyratos F, et al. Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach. Endocr Relat Cancer. 2006;13:1109–20.PubMedCrossRef
57.
Dorjgochoo T, Delahanty R, Lu W, Long J, Cai Q, Zheng Y, et al. Common genetic variants in the vitamin D pathway including genome-wide associated variants are not associated with breast cancer risk among Chinese women. Cancer Epidemiol Biomarker Prev. 2011;20:2313–6.CrossRef
Metadata
Title
TaqI polymorphism of VDR gene contributes to breast cancer risk
Authors
Hua Wang
Wenjian Wang
Dongjie Yang
Shenming Wang
Publication date
01-01-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 1/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-1011-9

Other articles of this Issue 1/2014

Tumor Biology 1/2014 Go to the issue

Research Article

A regulatory variant in CYP2E1 affects the risk of lung squamous cell carcinoma

Research Article

RETRACTED ARTICLE: Association between glutathione S-transferase M1 null variant and risk of bladder cancer in Chinese Han population

Research Article

Quantitative assessment of the association between +61A>G polymorphism of epidermal growth factor gene and susceptibility to glioma

Research Article

Quantitative assessment of the association between MTHFR rs1801131 polymorphism and risk of liver cancer

Research Article

Meta-analysis: glutathione S-transferase T1 null allele is associated with gastric cancer risk

Research Article

Thrombomodulin mediates the migration of cervical cancer cells through the regulation of epithelial–mesenchymal transition biomarkers
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits